Wildcat Capital Management’s Kite Pharma, Inc. KITE Stock Holding History

Wildcat Capital Management’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-2,410,034	Closed	-$433M	–	18
2017 Q3	$433M	Hold	2,410,034	–	–	77.71%	1
2017 Q2	$250M	Buy	2,410,034 +51,950	+2%	+$4.24M	66.42%	1
2017 Q1	$185M	Hold	2,358,084	–	–	58.62%	1
2016 Q4	$106M	Hold	2,358,084	–	–	48.63%	1
2016 Q3	$132M	Hold	2,358,084	–	–	39.7%	1
2016 Q2	$118M	Hold	2,358,084	–	–	44.43%	1
2016 Q1	$108M	Hold	2,358,084	–	–	37.65%	1
2015 Q4	$145M	Hold	2,358,084	–	–	41%	1
2015 Q3	$131M	Hold	2,358,084	–	–	49.02%	1
2015 Q2	$144M	Hold	2,358,084	–	–	49.28%	1
2015 Q1	$136M	Hold	2,358,084	–	–	52.71%	1
2014 Q4	$136M	Buy	+2,358,084	New	+$99.3M	55.97%	1

Wildcat Capital Management's KITE Position: Q4 2017 in Review

Wildcat Capital Management sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 2,410,034 shares — an estimated $433M sold.

Wildcat Capital Management first reported a position in KITE in Q4 2014 and held it in 12 quarters. The position peaked at $433M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

Wildcat Capital Management reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
Wildcat Capital Management sold 2,410,034 Kite Pharma, Inc. shares in Q4 2017, an estimated $433M.
Wildcat Capital Management first reported a position in Kite Pharma, Inc. in Q4 2014 and held it in 12 quarters.
Wildcat Capital Management's Kite Pharma, Inc. position peaked at $433M in Q3 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Wildcat Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.